Table 1 Coarse clustering results.
Coarse cluster name | Descriptive statistics | Prevalent diagnoses | Enriched diagnoses | Prevalent procedures | Enriched procedures |
|---|---|---|---|---|---|
Population | N = 49599 43.9% female Age: 66 years (53, 78) ICU stay - all: 2 days (1, 4) - survivors: 2 days (1, 4) - deceased: 3 days (1, 6) 28-day mortality: 13.6% | 401.9 - Unspecified essential hypertension (41.3%), 414.0 Coronary atherosclerosis (27.9%), 427.3 Atrial fibrillation and flutter (26.6%), 428.0 - Congestive heart failure, unspecified (26.2%), 250.0 Diabetes mellitus without mention of complication or manifestation classifiable to 250.1–250.9 (19.7%), 518.8 Other disease of lung (19.5%), 584.9 - Acute kidney failure, unspecified (18.2%), 272.4 - Other and unspecified hyperlipidemia (17.4%), V58.6 Long-term (current) drug use (14.1%), 530.8 Other specified disorders of esophagus (13.2%), 599.0 - Urinary tract infection, site not specified (13.1%), V45.8 Other postprocedural status (12.3%), 403.9 Unspecified hypertensive kidney disease (12.1%), 272.0 - Pure hypercholesterolemia (11.8%), 995.9 Systemic inflammatory response syndrome (SIRS) (10.8%) | – | 38.93 - Venous catheterization, not elsewhere classified (25.1%), 96.04 - Insertion of endotracheal tube (17.0%), 96.71 - Continuous invasive mechanical ventilation for less than 96 consecutive hours (15.6%), 96.6 - Enteral infusion of concentrated nutritional substances (14.9%), 99.04 - Transfusion of packed cells (13.8%), 39.61 - Extracorporeal circulation auxiliary to open heart surgery (13.6%), 96.72 - Continuous invasive mechanical ventilation for 96 consecutive hours or more (11.2%), 88.56 - Coronary arteriography using two catheters (10.2%), 36.15 - Single internal mammary-coronary artery bypass (8.8%), 38.91 - Arterial catheterization (8.7%), 88.72 - Diagnostic ultrasound of heart (6.6%), 37.22 - Left heart cardiac catheterization (6.4%), 39.95 - Hemodialysis (6.4%), 99.15 - Parenteral infusion of concentrated nutritional substances (5.9%), 33.24 - Closed [endoscopic] biopsy of bronchus (5.3%) | – |
Cluster 1 | N = 19147 78.1% female Age: 69 years (55, 81) ICU stay - all: 3 days (1, 6) - survivors: 3 days (1, 6) - deceased: 3 days (1, 7) 28-day mortality: 23.5% | \(\sim\) 401.9 - Unspecified essential hypertension (40.3%, -3.9%), + 518.8 Other disease of lung (29.2%, +118.1%), + 428.0 - Congestive heart failure, unspecified (28.5%, +15.1%), \(\sim\) 427.3 Atrial fibrillation and flutter (27.2%, +3.9%), + 584.9 - Acute kidney failure, unspecified (21.1%, +28.4%), − 414.0 Coronary atherosclerosis (20.3%, -38.0%), \(\sim\) 250.0 Diabetes mellitus without mention of complication or manifestation classifiable to 250.1-250.9 (19.8%, +1.3%), + 599.0 - Urinary tract infection, site not specified (18.2%, +84.1%), \(\sim\) 272.4 - Other and unspecified hyperlipidemia (17.0%, -3.7%), + V58.6 Long-term (current) drug use (16.2%, +26.4%), + 995.9 Systemic inflammatory response syndrome (SIRS) (14.9%, +81.6%), + 244.9 - Unspecified acquired hypothyroidism (13.7%, +85.6%), \(\sim\) 530.8 Other specified disorders of esophagus (13.4%, +2.8%) | + 518.8 Other disease of lung (29.2%, +118.1%), − 414.0 Coronary atherosclerosis (20.3%, -38.0%), − 600.0 Hypertrophy (benign) of prostate (1.0%, -82.9%), + 599.0 - Urinary tract infection, site not specified (18.2%, +84.1%), + 733.0 Osteoporosis (6.9%, +219.8%), + 785.5 Shock without mention of trauma (12.7%, +112.0%), + 995.9 Systemic inflammatory response syndrome (SIRS) (14.9%, +81.6%), + 038.9 - Unspecified septicemia (10.9%, +106.3%), + 244.9 - Unspecified acquired hypothyroidism (13.7%, +85.6%), + 294 Persistent mental disorders due to conditions classified elsewhere (6.6%, +174.6%), + 518.5 Pulmonary insufficiency following trauma and surgery (6.2%, +131.0%), + 276.2 - Acidosis (11.9%, +67.5%), + 507.0 - Pneumonitis due to inhalation of food or vomitus (9.9%, +72.4%) | + 38.93 - Venous catheterization, not elsewhere classified (31.8%, +52.1%), + 96.04 - Insertion of endotracheal tube (26.7%, +144.9%), + 96.6 - Enteral infusion of concentrated nutritional substances (23.0%, +132.5%), + 96.71 - Continuous invasive mechanical ventilation for less than 96 consecutive hours (21.7%, +84.7%), + 96.72 - Continuous invasive mechanical ventilation for 96 consecutive hours or more (19.7%, +240.9%), − 99.04 - Transfusion of packed cells (13.0%, -9.0%), + 38.91 - Arterial catheterization (12.7%, +104.2%), + 99.15 - Parenteral infusion of concentrated nutritional substances (7.9%, +69.6%), − 39.61 - Extracorporeal circulation auxiliary to open heart surgery (7.6%, -56.0%), + 39.95 - Hemodialysis (7.3%, +26.8%), − 88.56 - Coronary arteriography using two catheters (7.1%, -42.0%), + 33.24 - Closed [endoscopic] biopsy of bronchus (7.0%, +68.0%), + 31.1 - Temporary tracheostomy (6.1%, +236.4%) | + 96.04 - Insertion of endotracheal tube (26.7%, +144.9%), + 96.6 - Enteral infusion of concentrated nutritional substances (23.0%, +132.5%), + 96.72 - Continuous invasive mechanical ventilation for 96 consecutive hours or more (19.7%, +240.9%), − 36.15 - Single internal mammary-coronary artery bypass (3.9%, -67.4%), − 39.61 - Extracorporeal circulation auxiliary to open heart surgery (7.6%, -56.0%), + 96.71 - Continuous invasive mechanical ventilation for less than 96 consecutive hours (21.7%, +84.7%), + 38.93 - Venous catheterization, not elsewhere classified (31.8%, +52.1%), + 31.1 - Temporary tracheostomy (6.1%, +236.4%), + 38.91 - Arterial catheterization (12.7%, +104.2%), + 43.11 - Percutaneous [endoscopic] gastrostomy [PEG] (5.1%, +198.1%), − 36.12 - (Aorto)coronary bypass of two coronary arteries (1.8%, -64.2%), − 88.56 - Coronary arteriography using two catheters (7.1%, -42.0%), − 37.22 - Left heart cardiac catheterization (4.0%, -49.4%) |
Cluster 2 | N = 30452 22.3% female Age: 64 years (52, 76) ICU stay - all: 2 days (1, 4) - survivors: 2 days (1, 4) - deceased: 3 days (1, 6) 28-day mortality: 7.3% | \(\sim\) 401.9 - Unspecified essential hypertension (41.9%, +4.0%), + 414.0 Coronary atherosclerosis (32.7%, +61.4%), \(\sim\) 427.3 Atrial fibrillation and flutter (26.2%, -3.8%), − 428.0 - Congestive heart failure, unspecified (24.7%, -13.1%), \(\sim\) 250.0 Diabetes mellitus without mention of complication or manifestation classifiable to 250.1-250.9 (19.6%, -1.3%), \(\sim\) 272.4 - Other and unspecified hyperlipidemia (17.7%, +3.8%), − 584.9 - Acute kidney failure, unspecified (16.4%, -22.1%), + 272.0 - Pure hypercholesterolemia (13.8%, +56.6%), + V45.8 Other postprocedural status (13.5%, +30.4%), − 518.8 Other disease of lung (13.4%, -54.1%), \(\sim\) 530.8 Other specified disorders of esophagus (13.0%, -2.7%), − V58.6 Long-term (current) drug use (12.8%, -20.9%), \(\sim\) 403.9 Unspecified hypertensive kidney disease (12.0%, -2.9%) | − 518.8 Other disease of lung (13.4%, -54.1%), + 414.0 Coronary atherosclerosis (32.7%, +61.4%), + 600.0 Hypertrophy (benign) of prostate (5.6%, +485.5%), − 599.0 - Urinary tract infection, site not specified (9.9%, -45.7%), − 733.0 Osteoporosis (2.2%, -68.7%), − 785.5 Shock without mention of trauma (6.0%, -52.8%), − 995.9 Systemic inflammatory response syndrome (SIRS) (8.2%, -44.9%), − 038.9 - Unspecified septicemia (5.3%, -51.5%), − 244.9 - Unspecified acquired hypothyroidism (7.4%, -46.1%), − 294 Persistent mental disorders due to conditions classified elsewhere (2.4%, -63.6%), − 518.5 Pulmonary insufficiency following trauma and surgery (2.7%, -56.7%), − 276.2 - Acidosis (7.1%, -40.3%), − 507.0 - Pneumonitis due to inhalation of food or vomitus (5.7%, -42.0%) | − 38.93 - Venous catheterization, not elsewhere classified (20.9%, -34.3%), + 39.61 - Extracorporeal circulation auxiliary to open heart surgery (17.3%, +127.3%), + 99.04 - Transfusion of packed cells (14.3%, +9.9%), + 88.56 - Coronary arteriography using two catheters (12.2%, +72.4%), + 36.15 - Single internal mammary-coronary artery bypass (11.9%, +206.4%), − 96.71 - Continuous invasive mechanical ventilation for less than 96 consecutive hours (11.7%, -45.9%), − 96.04 - Insertion of endotracheal tube (10.9%, -59.2%), − 96.6 - Enteral infusion of concentrated nutritional substances (9.9%, -57.0%), + 37.22 - Left heart cardiac catheterization (7.9%, +97.6%), + 88.72 - Diagnostic ultrasound of heart (7.3%, +31.2%), − 38.91 - Arterial catheterization (6.2%, -51.0%), + 37.23 - Combined right and left heart cardiac catheterization (6.1%, +55.0%), − 96.72 - Continuous invasive mechanical ventilation for 96 consecutive hours or more (5.8%, -70.7%) | − 96.04 - Insertion of endotracheal tube (10.9%, -59.2%), − 96.6 - Enteral infusion of concentrated nutritional substances (9.9%, -57.0%), − 96.72 - Continuous invasive mechanical ventilation for 96 consecutive hours or more (5.8%, -70.7%), + 36.15 - Single internal mammary-coronary artery bypass (11.9%, +206.4%), + 39.61 - Extracorporeal circulation auxiliary to open heart surgery (17.3%, +127.3%), − 96.71 - Continuous invasive mechanical ventilation for less than 96 consecutive hours (11.7%, -45.9%), − 38.93 - Venous catheterization, not elsewhere classified (20.9%, -34.3%), − 31.1 - Temporary tracheostomy (1.8%, -70.3%), − 38.91 - Arterial catheterization (6.2%, -51.0%), − 43.11 - Percutaneous [endoscopic] gastrostomy [PEG] (1.7%, -66.4%), + 36.12 - (Aorto)coronary bypass of two coronary arteries (5.1%, +179.5%), + 88.56 - Coronary arteriography using two catheters (12.2%, +72.4%), + 37.22 - Left heart cardiac catheterization (7.9%, +97.6%) |